Company Name, Ticker, Suppliers, else..

Pro dex Inc (NASDAQ: PDEX)

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Pro Dex Inc 's

Name: Pro Dex Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PDEX Sales vs. its Competitors Q3 2026

Comparing the current results to its competitors, Pro Dex Inc reported Revenue increase in the 3 quarter 2026 by 14.56 % year on year.
The sales growth was above Pro Dex Inc 's competitors' average revenue growth of 1.86 %, achieved in the same quarter.

• List of PDEX Competitors

With a net margin of 19.74 % Pro Dex Inc achieved higher profitability than its competitors.

• More on PDEX Profitability Comparisons

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Pro dex Inc Net Income in the 3 quarter 2026 grew year on year by 20.24%, faster than the Pro Dex Inc 's competitors .

<< PDEX Stock Performance Comparisons

Pro Dex Inc 's Comment on Competition and Industry Peers

The company operates in highly competitive markets serving the medical device industry. It faces competition from major medical device companies with greater name recognition and resources, as well as from the internal development and manufacturing groups of its customers. Competitive pressures, including new product or technology introductions by the company, its customers, or competitors, may result in price reductions or loss of market share, which could negatively impact the business. There is no guarantee that the company's products and services will achieve widespread market acceptance or successfully compete with other products targeting the same customers.

<< See the full list of PDEX competitors

Overall company Market Share Q3 2026

Pro dex Inc achieved revenue growth of 14.56 % in Overall company, and improved market share, to approximately 1.65 %. << More on PDEX Market Share.

*Market share is calculated based on total revenue.

PDEX's Stock Performance relative to its Competitors

Publicly Traded Peers of Pro dex Inc

Apyx Medical Corp
Share Performance

+54.77%

One Year

Apyx Medical Corp

Profile

Apyx Medical Corporation follows a business model that centers around the development, manufacturing, and marketing of medical devices used in the field of aesthetics and surgical markets. The company focuses on creating innovative products that improve patient outcomes and enhance the effectiveness of surgical procedures. Apyx Medical Corporation sells its devices primarily through a direct sales force in the United States, while utilizing a combination of direct sales representatives and distributors in international markets.

More about Apyx Medical Corp's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 134.725 mill.	$ 55.304 mill.	$ -9.076 mill.

Mimedx Group Inc
Share Performance

-29.78%

This Year

Mimedx Group Inc

Profile

MiMedx Group Inc's business model revolves around developing and commercializing regenerative biologics to aid the body's natural healing process.

More about Mimedx Group Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 672.471 mill.	$ 354.086 mill.	$ 6.237 mill.

Neuropace Inc
Share Performance

-11.79%

This Quarter

Neuropace Inc

Profile

Neuropace Inc's business model revolves around the development and commercialization of medical devices for the treatment of neurological disorders, primarily focusing on epilepsy.

More about Neuropace Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 491.928 mill.	$ 98.926 mill.	$ -21.565 mill.

Nuo Therapeutics Inc
Share Performance

0.00%

Over The Past 5 Days

Nuo Therapeutics Inc

Profile

Nuo Therapeutics Inc's business model revolves around developing and commercializing innovative biologic therapies aimed at improving healthcare outcomes for patients. They focus on the research, development, and marketing of new therapeutic products, primarily in the wound care sector.

More about Nuo Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 4.036 mill.	$ -2.385 mill.

Pulse Biosciences Inc
Share Performance

+1.53%

Over The Past 5 Days

Pulse Biosciences Inc

Profile

Pulse Biosciences Inc's business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.

More about Pulse Biosciences Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 3,382.730 mill.	$ 0.751 mill.	$ -74.567 mill.

14 more competitors available

Sources: Pro dex Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, August 30, 2026 2:58 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Pro dex Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.